Neal Carnes

Neal Carnes

Auto-generated profile, based on publicly available information

Neal Carnes

Division of HIV Prevention, STD and TB Prevention, Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, Atlanta, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in American Journal of Preventive Medicine
Verified
Journal Article
Open access
DBDita Broz
Dita Broz
NCNeal Carnes
Neal Carnes
JCJohanna Chapin-Bardales
Johanna Chapin-Bardales
DJDon C. Des Jarlais
Don C. Des Jarlais
SHSenad Handanagic
Senad Handanagic
AAAlice K. Asher
Alice K. Asher
Diagnoses of HIV among people who inject drugs have increased in the U.S. during 2014-2018 for the first time in 2 decades, and multiple HIV outbreaks have been detected among people who inject drugs since 2015. These epidemiologic trends pose a significant concern for achieving goals of the federal initiative for Ending the HIV Epidemic in the U.S. Syringe services programs are cost effective, safe, and highly effective in reducing HIV transmission and are an essential component of a comprehensive, integrated approach to addressing these concerns. Yet, geographic coverage of these programs remains limited in the U.S., and many jurisdictions continue to have laws and policies that limit or disallow syringe services programs. An in-depth literature review was conducted on the role of syringe services programs in the Ending the HIV Epidemic initiative. Empirical and model-based evidence consistently shows that syringe services programs have the highest impact in HIV prevention when combined with access to medications for substance use disorder and antiretroviral therapy. Their effectiveness is further maximized when they provide services without restrictions and include proven and innovative strategies to expand access to harm-reduction and clinical services (e.g., peer outreach, telehealth). Increasing geographic and service coverage of syringe services programs requires strong and sustainable policy, funding, and community support and will need to address new challenges related to the COVID-19 pandemic. Syringe services programs have a key role in all 4 Ending the HIV Epidemic initiative strategies-Prevent, Diagnose, Treat, and Respond-and thus are instrumental to its success in preventing disease and saving lives.

21 August 2023 in Journal of Public Health Management & Practice
Verified
Journal Article
Closed access
GBGregorio J. Bautista
Gregorio J. Bautista
VMValerie Madera-Garcia
Valerie Madera-Garcia
RCRosalind J. Carter
Rosalind J. Carter
ASAmee Schwitters
Amee Schwitters
RBRamona Byrkit
Ramona Byrkit
JPJoseph Prejean
Joseph Prejean
Context: In response to the first reported mpox cases in May 2022, the US government implemented plans to bring testing, treatment, and vaccines to communities disproportionately affected by mpox—including the population of men who have sex with men (MSM) and Black/African American and Hispanic/Latino men, 2 subpopulations experiencing vaccination disparities. We describe the development and implementation of the US Mpox Vaccine Equity Pilot Program (MVEPP), characteristics of completed vaccination projects, and challenges that occurred. We also discuss opportunities for reducing vaccination disparities in future outbreaks. Program: To address reported vaccination disparities, the US government launched MVEPP in 2 phases. Phase 1 centered around public events attended by large numbers of gay, bisexual, and other MSM, such as Pride festivals. Phase 2 asked health departments to propose mpox vaccination projects specifically aimed at reducing or eliminating racial/ethnic and other demographic disparities in mpox vaccination. Implementation: MVEPP received 35 vaccination project proposals. We analyzed data from 22 completed projects that resulted in 25 675 doses of JYNNEOS administered. We note 3 innovative strategies that were implemented in several projects: direct collaboration with organizations providing services to MSM and transgender women; implementation of MVEPP projects in unique nonclinical community settings and at venues frequented by MSM and transgender women; and offering an array of services as part of mpox vaccination projects, rather than offering only mpox vaccination. Evaluation: MVEPP highlighted the importance of recognizing and working to eliminate racial/ethnic and other disparities in access to medical countermeasures during a public health emergency. Jurisdictions developed and implemented innovative strategies to bring mpox vaccination and related services to communities disproportionately affected by mpox—including MSM and the subpopulations of Black/African American and Hispanic/Latino MSM. Lessons learned from MVEPP may inform efforts to reduce disparities during future public health responses.

6 August 2021 in Substance Use & Misuse
Verified
Journal Article
Closed access
NCNeal A. Carnes
Neal A. Carnes
AAAlice K. Asher
Alice K. Asher
MBMichele K. Bohm
Michele K. Bohm
PBPatricia A. Bessler
Patricia A. Bessler
Syringe service programs (SSP) increasingly serve rural areas of the United States, yet little is known about access and perceived need for their services. Objectives: This paper presents the HIV a...

2 January 2020 in AIDS Care
Verified
Journal Article
Closed access
NCNeal A. Carnes
Neal A. Carnes
JCJames W. Carey
James W. Carey
DGDeborah J. Gelaude
Deborah J. Gelaude
DDDamian J. Denson
Damian J. Denson
PBPatricia A. Bessler
Patricia A. Bessler
Expeditious linkage and consistent engagement in medical care is important for people with HIV’s (PWH) health. One theory on fostering linkage and engagement involves HIV status disclosure to mobilize social support. To assess disclosure and social support’s association with linkage and engagement, we conducted a qualitative study sampling black and Latino men who have sex with men (MSM of color) in the U.S. Participants' narratives presented mixed results. For instance, several participants who reported delaying, inconsistent access, or detachment from care also reported disclosing for support purposes, yet sporadic engagement suggests that their disclosure or any subsequent social support have not assisted. The findings contribute to the literature that questions disclosure and social support’s influence on care engagement, especially when decontextualized from circumstances and intentions. Our findings suggest the mechanics of disclosure and social support require planned implementation if intending to affect outcomes, especially among MSM of color. From the findings, we explore steps that may bolster interventions seeking to anchor medical care engagement.

3 March 2025 in Journal of Racial and Ethnic Health Disparities
Verified
Journal Article
Closed access
PDF file
NCNeal Carnes
Neal Carnes
LKLinda J. Koenig
Linda J. Koenig
AWAisha L. Wilkes
Aisha L. Wilkes
DGDeborah Gelaude
Deborah Gelaude
YSYamir Salabarría-Peña
Yamir Salabarría-Peña
MJMarie Johnston
Marie Johnston